RxDoctor Payments Data

Linda van le, MD

Gynecologic Oncology · Chapel Hill, NCNPI 1073601365

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $450 of the $533 with a category attached, or 84.4%. GSK accounts for 96.5% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for gynecologic oncology clinicians in NC, where the typical reported total is $1,376.

$533in general payments, 2019–2025

Across 3 payments — averaging $177.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$515
  • Pacira Pharmaceuticals Incorporated$19
$1,414,157in research payments, 2019–2025

Across 193 payments — averaging $7327.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$393K
  • Clovis Oncology, Inc.$312K
  • Tesaro, Inc.$109K
  • GSK$103K
  • AbbVie$99K
  • Genmab U.S., Inc.$92K
  • plus $306K from 8 others

What the payments were for

  • Consulting fees$45084%
  • Food & beverage$194%
  • Education$6512%

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK2$515
Pacira Pharmaceuticals Incorporated1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$533 in reported general payments places this provider in the 30th percentile of 52 gynecologic oncology providers in North Carolina.

See all gynecologic oncology providers in North Carolina

Medicare billing

Part B allowed, 2024
$9,796
Medicare patients
50
Services billed
100

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gynecologic oncology in Chapel Hill

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →